ELV - Centene downgraded at Morgan Stanley on concerns over earnings growth
2023-08-30 12:35:30 ET
More on Centene
- Centene's Growth Story: Unraveling The Potential Of A Profitable Powerhouse
- Centene: Results Impress But Buyers Aren't Swarming Yet
- Centene to sell U.K. hospital operator Circle Health for $1.2B
- Centene falls despite guidance raise amid Medicaid impact
- Wolfe downgrades Centene to peer perform, citing cost concerns
- Seeking Alpha’s Quant Rating on Centene
For further details see:
Centene downgraded at Morgan Stanley on concerns over earnings growth